Alkermes plc’s recent filing unveils that its EVP R&D, Chief Medical Officer Hopkinson Craig C. unloaded Company’s shares for reported $1.77 million on Nov 11 ’24. In the deal valued at $30.08 per share,58,996 shares were sold. As a result of this transaction, Hopkinson Craig C. now holds 83,300 shares worth roughly $2.29 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Hopkinson Craig C. bought 58,996 shares, generating $1,774,578 in total proceeds.
Before that, Hopkinson Craig C. sold 10,471 shares. Alkermes plc shares valued at $309,169 were divested by the EVP R&D, Chief Medical Officer at a price of $29.53 per share. As a result of the transaction, Hopkinson Craig C. now holds 99,238 shares, worth roughly $2.73 million.
Stifel upgraded its Alkermes plc [ALKS] rating to a Buy from a a Hold in a research note published on November 05, 2024; the price target was increased to $36 from $25. A number of analysts have revised their coverage, including TD Cowen’s analysts, who began to cover the stock in mid June with a ‘”a Buy”‘ rating. Robert W. Baird began covering ALKS with “an Outperform” recommendation on March 19, 2024. UBS revised its rating on February 20, 2024. It rated ALKS as “a Sell” which previously was an “a Neutral”.
Price Performance Review of ALKS
On Monday, Alkermes plc [NASDAQ:ALKS] saw its stock fall -2.27% to $27.55. Over the last five days, the stock has lost -8.40%. Alkermes plc shares have fallen nearly -0.68% since the year began. Nevertheless, the stocks have risen 17.89% over the past one year. While a 52-week high of $32.88 was reached on 02/16/24, a 52-week low of $22.06 was recorded on 07/10/24. SMA at 50 days reached $27.80, while 200 days put it at $26.58.
Levels Of Support And Resistance For ALKS Stock
The 24-hour chart illustrates a support level at 27.16, which if violated will result in even more drops to 26.76. On the upside, there is a resistance level at 28.21. A further resistance level may holdings at 28.86. The Relative Strength Index (RSI) on the 14-day chart is 46.84, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.06, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 59.40%. Stochastics %K at 50.97% indicates the stock is a holding.
How much short interest is there in Alkermes plc?
A steep rise in short interest was recorded in Alkermes plc stocks on 2024-10-31, dropping by -1.06 million shares to a total of 16.12 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 17.18 million shares. There was a decline of -6.57%, which implies that there is a negative sentiment for the stock.
